OVERVIEW
The Global 3D Bioprinting Market is calculated to reach USD 1665.23 million by 2024, growing at a CAGR of 20.23% during the forecast period 2019-2024. The global 3D bioprinting market is expected to experience growth owing to its revolutionary breakthrough in healthcare and pharmaceutical industries. The growing technological advancements, government intervention for improving healthcare, and increasing investments in R&D are also significant factors driving the studied market growth.
TABLE OF CONTENT
1 Global 3D Bioprinting Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global 3D Bioprinting Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global 3D Bioprinting Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global 3D Bioprinting Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global 3D Bioprinting Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global 3D Bioprinting Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global 3D Bioprinting Market – By Component (Market Size – & million/billion)
8.1 3D Bioprinters
8.2 Biomaterials
8.3 Scaffolds
9 Global 3D Bioprinting Market – By Technology
9.1 Syringe/Extrusion Bioprinting
9.2 Inkjet Bioprinting
9.3 Magnetic Levitation Bioprinting
9.4 Laser-assisted Bioprinting
9.5 Other
10 Global 3D Bioprinting Market – By Application
10.1 Drug Testing and Development
10.2 Regenerative Medicine
10.3 Food Testing
10.4 Research
10.5 Other
11 Global 3D Bioprinting Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global 3D Bioprinting Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships13 Global 3D Bioprinting Market Company Profile (Key Players)
13 Global 3D Bioprinting Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Advanced Solutions Life Sciences
13.3 Allevi Inc.
13.4 Envisiontec
13.5 Gesim
13.6 Aspect Biosystems Ltd.
13.7 Cellink
13.8 Nano3D Biosciences, Inc.
13.9 Cyfuse Biomedical K.K.
13.10 Digilab, Inc.
13.11 Poietis
13.12 Company 11 & more
14 Global 3D Bioprinting Market – Appendix
14.1 Sources
14.2 Abbreviations